APA |
Bingol, H. ., Us, M. ., Cingoz, F. ., Yilmaz, A. ., et al. (2002). Does Terlipressin Acetate Reduce the Complications of Systemic Inflammatory Response Syndrome?. Koşuyolu Kalp Dergisi, 6(2), 57-63. |
|
AMA |
Bingol H, Us M, Cingoz F, Yilmaz A, Tatar H. Does Terlipressin Acetate Reduce the Complications of Systemic Inflammatory Response Syndrome?. Koşuyolu Kalp Dergisi. February 2002;6(2):57-63. |
|
Chicago |
Bingol, H., M.H Us, F. Cingoz, A.t Yilmaz, and H. Tatar. “Does Terlipressin Acetate Reduce the Complications of Systemic Inflammatory Response Syndrome?”. Koşuyolu Kalp Dergisi 6, no. 2 (February 2002): 57-63. |
|
EndNote |
Bingol H, Us M, Cingoz F, Yilmaz A, Tatar H (February 1, 2002) Does Terlipressin Acetate Reduce the Complications of Systemic Inflammatory Response Syndrome?. Koşuyolu Kalp Dergisi 6 2 57–63. |
|
IEEE |
H. . Bingol, M. . Us, F. . Cingoz, A. . Yilmaz, and H. . Tatar, “Does Terlipressin Acetate Reduce the Complications of Systemic Inflammatory Response Syndrome?”, Koşuyolu Kalp Dergisi, vol. 6, no. 2, pp. 57–63, 2002. |
|
ISNAD |
Bingol, H. et al. “Does Terlipressin Acetate Reduce the Complications of Systemic Inflammatory Response Syndrome?”. Koşuyolu Kalp Dergisi 6/2 (February 2002), 57-63. |
|
JAMA |
Bingol H, Us M, Cingoz F, Yilmaz A, Tatar H. Does Terlipressin Acetate Reduce the Complications of Systemic Inflammatory Response Syndrome?. Koşuyolu Kalp Dergisi. 2002;6:57–63. |
|
MLA |
Bingol, H. et al. “Does Terlipressin Acetate Reduce the Complications of Systemic Inflammatory Response Syndrome?”. Koşuyolu Kalp Dergisi, vol. 6, no. 2, 2002, pp. 57-63. |
|
Vancouver |
Bingol H, Us M, Cingoz F, Yilmaz A, Tatar H. Does Terlipressin Acetate Reduce the Complications of Systemic Inflammatory Response Syndrome?. Koşuyolu Kalp Dergisi. 2002;6(2):57-63. |
|